Tuesday, August 19, 2014 3:28:09 PM
Simple fact is that the company managed to do all of these things, including a transaction bringing the company toward a revenue positive EPS, while not having to issue a ton of dilutive stock. The number of outstanding is now less than what it was in Q1, and they acquired a company providing over $1.6 million in gross revenues.
Not a bad thing in my opinion.
According to all reports, all shares issued are restricted, outside of the reported free-trading. That has not changed much for an extended period of time.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM